Anti-ABHD12 antibodies are used in the immunodetection of the protein abhydrolase domain containing 12, lysophospholipase. In humans, the canonical protein has a reported length of 398 amino acid residues and a mass of 45.1 kDa. Its subcellular localization is in the ER. Up to 3 different isoforms have been reported for this protein. A member of the Serine esterase protein family, ABHD12 is known to be involved with the metabolism of lipids. Post-translational modifications have been described, including glycosylation. The ABHD12 gene has been associated with the disease, Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract. Synonyms for this target antigen include BEM46L2, C20orf22, PHARC, dJ965G21.2, hABHD12, and ABHD12A. ABHD12 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of ABHD12 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.